CNR Institutional Research Information System

UGONE, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.046
NA - Nord America 938
EU - Europa 454
SA - Sud America 235
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 31
OC - Oceania 1
Totale 2.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 882
SG - Singapore 465
IT - Italia 215
CN - Cina 196
BR - Brasile 174
HK - Hong Kong 127
VN - Vietnam 122
FR - Francia 69
BD - Bangladesh 38
NL - Olanda 37
CA - Canada 26
AR - Argentina 23
GB - Regno Unito 22
FI - Finlandia 18
MX - Messico 18
EC - Ecuador 16
DE - Germania 15
IN - India 15
KR - Corea 14
ID - Indonesia 11
AT - Austria 10
IE - Irlanda 10
CO - Colombia 9
JP - Giappone 9
SE - Svezia 9
ES - Italia 8
TR - Turchia 7
ZA - Sudafrica 7
UA - Ucraina 6
IQ - Iraq 5
MA - Marocco 5
PL - Polonia 5
PT - Portogallo 5
RO - Romania 5
LT - Lituania 4
PK - Pakistan 4
PY - Paraguay 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
DZ - Algeria 3
JM - Giamaica 3
KZ - Kazakistan 3
NG - Nigeria 3
RU - Federazione Russa 3
TH - Thailandia 3
TN - Tunisia 3
VE - Venezuela 3
AZ - Azerbaigian 2
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
MY - Malesia 2
OM - Oman 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 2.705
Salva come PNG Salva come JPEG
Città #
Singapore 253
Santa Clara 232
Hong Kong 126
Ashburn 96
San Jose 70
Los Angeles 48
Beijing 47
Lauterbourg 46
Ho Chi Minh City 44
Hanoi 37
Milan 30
Hefei 28
São Paulo 27
Sala Baganza 26
Amsterdam 24
Dallas 18
Guangzhou 17
New York 17
Cavallino 16
Genoa 14
Lappeenranta 14
Seoul 13
Turin 13
Cagliari 11
Orem 11
Vienna 10
Denver 9
Bitonto 8
Buffalo 8
Dublin 8
Frankfurt am Main 8
Phoenix 8
Quito 8
Stockholm 8
Boston 7
Houston 7
Naples 7
Rome 7
Boardman 6
Bologna 6
Brasília 6
Dhaka 6
Montreal 6
Poplar 6
Tokyo 6
Afragola 5
Brooklyn 5
Chicago 5
Council Bluffs 5
Da Nang 5
Florence 5
Querétaro 5
Betim 4
Bucharest 4
Haiphong 4
Inglewood 4
Johannesburg 4
London 4
Louisville 4
Portsmouth 4
Pueblo 4
Warsaw 4
Ananindeua 3
Baltimore 3
Belo Horizonte 3
Biên Hòa 3
Campinas 3
Charlotte 3
Chennai 3
Curitiba 3
Dubai 3
Düsseldorf 3
Florianópolis 3
Guayaquil 3
Miami 3
Palermo 3
Paris 3
Richmond 3
Rio de Janeiro 3
Springfield 3
Tempio Pausania 3
Trieste 3
Washington 3
Windsor 3
Almaty 2
Ambato 2
Antakya 2
Arapiraca 2
Atlanta 2
Austin 2
Baku 2
Blumenau 2
Bogotá 2
Brazzaville 2
Bridgetown 2
Bình Dương 2
Bình Dương Province 2
Cairo 2
Camaragibe 2
Can Tho 2
Totale 1.596
Salva come PNG Salva come JPEG
Nome #
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 102
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 91
Vanadium-proteins. Structure, binding, characterization and biological implications 79
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 76
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 75
Antioxidant Properties and Radical Production Capability of the Potential Antitumor V(IV)O Complexes Formed by Flavonoid Ligands 71
Covalent and non-covalent binding in vanadium-protein adducts 69
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 65
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A 65
A Study on the Photoisomerization of (E)-Dehydrozingerone, Its (E)-(E)-C₂ Symmetric Dimer, and Their O-Methylated Derivatives 64
Thermodynamic study of oxidovanadium(Iv) with kojic acid derivatives: A multi-technique approach 64
Speciation and biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 62
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug. 61
Influence of temperature on the equilibria of oxidovanadium(iv) complexes in solution 59
Interaction of vanadium(IV,V) coordination complexes with proteins 58
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 56
Nonoxido V(IV) complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 55
Interaction of the potent antitumoral compounds Casiopeinas® with blood serum and cellular bioligands 55
In-Depth Mass Spectrometry Study of Vanadium(IV) Complexes with Model Peptides 54
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability 50
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies 50
Interaction of vanadocene dichloride with the blood serum components 49
Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems 48
Biotransformation of oxidovanadium(IV) complexes with oxydiacetate and NN-heterocycles 48
Interaction of pharmacologically active pyrone and pyridinone vanadium(IV,V) complexes with cytochrome c 48
Speciation of vanadocene dichloride in the blood plasma 47
Biotransformation in the blood serum of potential antitumor V(IV)O2+ complexes and interaction with red blood cells 47
Characterization of oxidovanadium(IV) complexes with quinolones 46
Interaction of V(V) complexes formed by picolinic and pyrazinecarboxylic acid derivatives with red blood cells 46
Novel porphyrin-containing hydrogels obtained by frontal polymerization: Synthesis, characterization and optical properties 45
Integrated instrumental/computational methods to characterize the binding to proteins and biospeciation of potential vanadium drugs 43
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 43
Characterization and biotransformation in the plasma and red blood cells of VIVO2+ complexes formed by ceftriaxone 43
Interaction of vanadium compounds with Cytochrome c 41
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin 41
Interaction of potential vanadium drugs with proteins studied by an experimental and computational approach 38
Speciation of potential anti-diabetic vanadium complexes in real serum samples 38
Equilibrium between Different Coordination Geometries in Oxidovanadium(IV) Complexes. 38
Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach 37
VO complexes with antibacterial quinolone ligands and their interaction with serum proteins. 37
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH. 37
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug-myoglobin application 37
Biotransformation in the blood serum of potential antitumor V(IV)O2+ complexes and interaction with red blood cells 36
Binding of potential antitumor Casiopeínas® to small proteins 35
Characterization of the coordination modes of flavonoids towards oxidovanadium(IV) 35
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 34
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 34
Integrative spectroscopic-docking methods for the study of the interaction between vanadium complexes and proteins 33
Evaluation of antifungal and antimycotoxigenic activity of selected natural antioxidants against Fusarium culmorum: in vitro and in planta assays 32
Decoding Surface Interaction of V(IV)O Metallodrug Candidates with Lysozyme 31
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 30
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations. 29
V(IV)O and V(IV) Species Formed in Aqueous Solution by the Tridentate Glutaroimide-Dioxime Ligand - An Instrumental and Computational Characterization 29
Temperature and Solvent Structure Dependence of VO2+ Complexes of Pyridine-N-oxide Derivatives 27
Estratto fenolico di bacche di mirto comune e composizione farmaceutica orale contenente il suddetto estratto in combinazione con un complesso di vanadio 27
Synthesis, crystal structures, EPR and DFT studies of first row transition metal complexes of lignin model compound ethylvanillin 26
Effect of secondary interactions, steric hindrance and electric charge on the interaction of V(IV)O species with proteins 24
Complex formation between [(eta(6)-p-cym)Ru(H2O)(3)](2+) and oligopeptides containing three histidyl moieties 24
Mixed-Ligand Complex Formation in the Systems Containing the Potential Drug [VIVO(acac)2] with Blood and Cellular Bioligands. Implications on the Active Species Formed in the Organism 10
Totale 2.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.512
article - articoli 7.025
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202458 0 0 0 0 0 0 0 0 26 9 15 8
2024/2025949 110 5 77 29 158 60 8 54 65 40 198 145
2025/20261.481 42 79 102 250 322 112 185 86 85 99 58 61
2026/2027286 101 68 117 0 0 0 0 0 0 0 0 0
Totale 2.774